Skip to main content

Table 3 Measurement methods

From: Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates

Measurement

Measurement method

BMD

DXA (QDR4500, Hologic Inc., Bedford. MA)

NTX

TRACP-5b

ELISA (Alere Medical, Japan)

ELISA (DS Pharma Biomedical, Japan)

PICP

ELISA (Takara, Japan)

RANKL

ELISA (Biomedica, Vienna, Austria)

  1. BMD, bone mineral density; NTX, N-terminal telopeptide of type I collagen; TRACP-5b, tartrate-resistant acid phosphate-5b; PICP, C-terminal propeptide of type I procollagen; RANKL, receptor activator of NF-κB ligand; DXA, dual-energy x-ray absorptiometry; ELISA, enzyme-linked immunosorbent assay.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us